Apellis Pharmaceuticals, INC. (APLS) SEC Filings — 2025
9 SEC filings for Apellis Pharmaceuticals, INC. (APLS) in 2025.
Filings
- Apellis Swings to Profit on Soaring Licensing Revenue — 10-Q · Oct 30, 2025
- Apellis Widens Q2 Loss Amid SYFOVRE Commercial Push — 10-Q · Jul 31, 2025
- Apellis Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jul 1, 2025
- Apellis Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 4, 2025
- Apellis Pharmaceuticals Q1 2025 10-Q Filing — 10-Q · May 7, 2025
- Apellis Pharma DEF 14A: Executive Compensation Details — DEF 14A · Apr 23, 2025
- Apellis Pharmaceuticals Announces Board and Executive Changes — 8-K · Apr 21, 2025
- Apellis Pharmaceuticals Files 2024 10-K — 10-K · Feb 28, 2025
- Apellis Pharmaceuticals Names New Chief Medical Officer — 8-K · Jan 13, 2025